Fortrea Holdings Inc. cash flow statement
In fiscal 2025, Fortrea Holdings Inc.'s operations generated $114m of cash; it spent $25.2m on capital projects, leaving free cash flow of $88.3m.
Cash flow statement
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 170 | 83 | 168 | 263 | 114 | 202 |
| Depreciation and amortisation | 166 | 94 | 98 | 87 | 78 | 79 |
| Stock-based pay | 28 | 25 | 43 | 58 | 74 | 51 |
| Capital spending | 27 | 54 | 40 | 26 | 25 | 33 |
| Free cash flow | 143 | 28 | 128 | 237 | 88 | 169 |
| Free cash flow after stock pay | 116 | 3 | 85 | 179 | 14 | 118 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 17 | −124 | 22 | 87 | 129 | −17 | 29 | 61 |
| Depreciation and amortisation | 21 | 20 | 20 | 20 | 19 | 20 | 20 | 20 |
| Stock-based pay | 15 | 15 | 23 | 22 | 15 | 11 | 13 | 12 |
| Capital spending | −3 | 3 | 8 | 7 | 8 | 8 | 9 | 8 |
| Free cash flow | 20 | −127 | 14 | 80 | 122 | −25 | 20 | 53 |
| Free cash flow after stock pay | 5 | −142 | −8 | 57 | 107 | −36 | 7 | 41 |
Compare with peers
- Bio-rad Laboratories, Inc. cash flow
- Medpace Holdings, Inc. cash flow
- Qiagen N.V. cash flow
- Bruker Corp cash flow
- Charles River Laboratories cash flow
Head to head: BIO vs FTREFTRE vs MEDPFTRE vs QGEN
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies